A study to evaluate efficacy and safety of obexelimab in patients with IgG4-related disease

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2024
This article has no abstract
Epistemonikos ID: 7eed3a862cb96206e71445c0e0b112b9d6aadd87
First added on: Jan 17, 2025